Kalytera Announces Binding Agreement to Acquire Salzman Group
Hit enter to search or ESC to close
Kalytera Therapeutics, Inc.
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact
Media Mentions

In Development: Cannabidiol Treatments [Pharmaceutical Processing]

By Kalytera November 11, 2015 December 30th, 2015 No Comments

In Development: Cannabidiol Treatments [Pharmaceutical Processing]

http://www.pharmpro.com/articles/2015/11/development-cannabidiol-treatments
Get Email Alerts Subscribe

New Website Coming Soon


© 2020 Kalytera Therapeutics, Inc.

Kalytera Announces Binding Agreement to Acquire Salzman Group
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact

© 2016 Kalytera Therapeutics, Inc.